Here's a picture of the possible future:
NASDAQ Listing.
Dubai then Australia begins treating patients with Ovarian Cancer.
They then begin treating patients with kidney, pancreatic, breast, colon, lung, and even prostate cancer...
Full FDA Approval in the US and Europe for Ovarian Cancer.
The Share price rockets and CVac acheives Global recognition.
Increasing numbers start flying to Dubai or Australia for treatment of kidney, pancreatic, breast, colon, and lung cancer...
Prima commences studies into the other Mucin-1 cancers...
People could then be saying, "One day this $5 per share company could be worth ten times as much."
- Forums
- ASX - By Stock
- IMM
- tough times ahead for dndn
IMM
immutep limited
Add to My Watchlist
2.00%
!
24.5¢

tough times ahead for dndn, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $357.7M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 24.0¢ | $419.2K | 1.737M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 301706 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 28117 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 192523 | 0.240 |
5 | 298882 | 0.235 |
10 | 327911 | 0.230 |
13 | 511200 | 0.225 |
17 | 1170248 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 8320 | 1 |
0.250 | 161392 | 6 |
0.255 | 106804 | 5 |
0.260 | 253203 | 7 |
0.265 | 486184 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online